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Abstract
Background: Halometabolites, an important group of natural products, generally require halogenases for their
biosynthesis. Actinomycetes from the Arctic Ocean have rarely been investigated for halogenases and their gene
clusters associated, albeit great potential of halometabolite production has been predicted. Therefore, we initiated
this research on the screening of halogenases from Arctic marine actinomycetes isolates to explore their genetic
potential of halometabolite biosynthesis.
Results: Nine halogenase genes were discovered from sixty Arctic marine actinomycetes using in-house designed
or previously reported PCR primers. Four representative genotypes were further cloned to obtain full coding
regions through genome walking. The resulting halogenases were predicted to be involved in halogenation of
indole groups, antitumor agent ansamitocin-like substrates, or unknown peptide-like compounds. Genome
sequencing revealed a potential gene cluster containing the halogenase predicted to catalyze peptide-like
compounds. However, the gene cluster was probably silent under the current conditions.
Conclusions: PCR-based screening of halogenase genes is a powerful and efficient tool to conduct bioprospecting
of halometabolite-producing actinomycetes from the Arctic. Genome sequencing can also identify cryptic gene
clusters potentially producing new halometabolites, which might be easily missed by traditional isolation and
chemical characterization. In addition, our study indicates that great genetic potential of new halometabolites can
be expected from mostly untapped actinomycetes from the polar regions.
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Background
Actinomycetes are especially important in producing
various bioactive secondary metabolites, including well-
known antibiotics such as chloramphenicol [1] and anti-
cancer molecules such as rebeccamycin [2]. Actinomycetes
isolated from terrestrial environments have been well stud-
ied, which results in frequent rediscovery of known natural
products [3, 4]. In contrast, marine actinomycetes from the
deep ocean or the polar regions are mostly untapped
resources [5]. Currently, new actinomycetes have been
described from the Arctic and Antarctica, using
cultivation-dependent and -independent approaches [6–9].
An increasing number of natural products have been
reported from marine actinomycetes as well [5, 10].
To meet the urgent medical needs of drug candidates,
advanced approaches are required to improve the effi-
ciency of natural product discovery [11–13]. Generally,
similar secondary metabolites are biosynthesized by gene
clusters that contain certain homologous genes [14, 15].
The presence of marker genes, such as polyketide syn-
thase (PKS), non-ribosomal peptide synthetase (NRPS)
genes and tailoring enzyme genes, may indicate produc-
tion of certain secondary metabolites. Therefore, PCR-
based marker gene screening is an efficient way to find
promising natural products from the environment [16].
Halogenation catalyzed by halogenases is an important
tailoring step for bioactivities of many natural products
[17, 18]. Halogenated natural products span from simple
halogenated indoles, terpenes and phenols to complex
oligopeptides and polyketides. Halogenated compounds
are important sources for new drugs, due to their high
diversity in structure and activity. More than 4,700 halo-
genated compounds have been reported, showing diverse
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biological activities and structures [19]. Some of them
have been used for decades as pharmaceuticals. For ex-
ample, the well-known antibiotic chloramphenicol [1],
the antitumor agent rebeccamycin [2] and the antifugal
antibiotic pyrrolnitrin [20] have been used widely in
clinic or currently under clinical trials. Therefore, explor-
ation of halometabolites is an important and promising
approach to discover new drugs. In addition to potential
biotechnological applications, antibiotics including halo-
metabolites are considered to be bacterial weapons for
fighting competitors in the indigenous ecosystems or
signals regulating the homeostasis of the microbial
communities [21]. Therefore, they may also have im-
portant ecological functions. Halogenase is a key tailor-
ing enzyme in producing halometabolites in nature and
can be used to explore halometabolites. Currently,
halogenases can be divided into two types [22]. One
type is highly substrate-specific, including flavin aden-
ine dinucleotide (FADH2)-dependent halogenases
(FDHs), non-heme FeII/α-ketoglutarate halogenases and
SAM-dependent halogenases. The other type is halo-
peroxidases that generally lack of substrate specificity.
FDHs are the major type of halogenases involved in
biosynthesis of halometabolites, and are usually indicative
of halometabolite types [23–25]. One group of well-studied
FDHs is tryptophan halogenases (Trp-halogenases) that
regioselectively halogenate tryptophan (e.g., [26–30]).
Halogenases from the polar regions and deep sea have
been much less investigated than from terrestrial environ-
ments and coasts. PCR-based screening of FDHs has been
conducted to study marine sponge-associated microbial
consortia [31] and actinomycetes from various terrestrial
and other environments [32]. FADH2-dependent halo-
genases have been studied in detail from marine and soil
actinomycetes, such as Amycolatopsis [33] and Streptomy-
ces [34], in the context of related gene clusters. However,
FDHs from the polar regions are poorly investigated. The
Arctic attracts increasing attention due to its unique
environmental conditions and strategic importance. Bio-
prospecting has been carried out in the Arctic for micro-
organisms in biotechnology [35, 36]. However, few reports
have been involved in halogenases. Previously, we detected
halogenase genes from Arctic actinomycetes without gene
cloning and sequencing [9]. In this study, we screened
FDHs from actinomycetes isolated from marine sediments
of the high Arctic, and sequenced them for the first time.
Novel FDH genes were further cloned to obtain the full
coding sequences for analysis. In addition, genome se-
quencing was performed to discover a cryptic gene cluster
predicted to produce an unknown halometabolite. Our
study showed that halogenase genes are helpful in bio-
prospecting Arctic actinomycetes. Great genetic potential
of halometabolite production can be expected from the
Arctic actinomycetes.
Results and Discussion
Bioprospecting for halogenase-containing actinomycetes
PCR-based screening was very efficient for bioprospect-
ing of halogenase-containing actinomycetes. Nine out of
60 strains were discovered to contain halogenase genes.
The 60 investigated actinomycetes strains were mostly
Streptomyces, with a few exceptions belonging to Nocar-
diopsis, Pseudonocardia and Brevibacterium (Additional
file 1: Table S1). Moderate frequency of occurrence of
halogenases was observed in Arctic actinomycetes,
compared with actinomycetes from other environments
[16, 32, 37]. The nine strains were distributed at various
water depths in the Arctic Ocean (Fig. 1), ranging from
shallow (e.g., 514 F at 173 m) to deep (e.g., 597 F at
2,531 m) marine sediments. They grew well at 15 °C in
ISPII medium (0.4 % yeast extract, 1.0 % malt extract,
0.4 % glucose), with the optimum temperature around
20 to 25 °C. No correlation between phylogenetic dis-
tances and geographic distribution was observed (Fig. 1).
The nine halogenase-containing strains were grouped
into two genera, Streptomyces (seven strains) and
Nocardiopsis (two strains) (Fig. 1). It agreed with previ-
ous studies that Streptomyces was the major genus con-
taining halogenases and also one of the most important
producers of halometabolites [16, 32, 38]. Nocardiopsis
is less commonly found containing halogenases. Indeed,
no halometabolites have been reported from Nocardiopsis
to the best of our knowledge. However, higher occurrence
of halogenases was observed in Nocardiopsis (2 out of 10)
than in Streptomyces (7 out of 49) in our study (Additional
file 1: Table S1), even though the sample size was not large
enough to show statistical significance. In addition, the
two Nocardiopsis strains were isolated from deep-sea sedi-
ments of the Arctic Ocean. Hence, the detection of two
halogenase-containing Nocardiopsis strains is of interest
and worthy of further investigation.
The closest type cultures of the nine strains are shown
in the phylogenetic tree (Fig. 1), sharing 99 to 100 % 16S
rRNA gene identities. The seven Streptomyces strains
could be clustered into three subgroups in the phylogen-
etic tree based on 16S rRNA genes (Fig. 1). To identify
whether halogenase genes are present in the closely
related strains, we searched the NCBI databases for gen-
ome and halogenase sequences of them. Only one gen-
ome of closely related strains was sequenced, i.e.,
Nocardiopsis lucentensis DSM 44048(T). However, no
halogenase genes were found in the draft genome of
Nocardiopsis lucentensis DSM 44048(T) [GenBank:
NZ_ANBC00000000.1]. In addition, no halogenase genes
were reported from the remaining closely related strains.
Analysis of putative halogenase partial sequences
The nine partial putative halogenase genes were amplified
by different degenerative primer pairs (Table 1), with five
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genes amplified by SZ002/SZ003/SZ005, three genes amp-
lified by Halo-B4-FW/Halo-B7-RV, and one gene ampli-
fied by Trp-RW/Trp-RV (Fig. 2). It seems that different
primer pairs have unequal efficiency, probably related to
primer sequences and the conserved domains targeted.
Hence, it suggests that more primers used for screening
can improve the opportunity of finding halogenases. In
addition, false positives occurred more frequently using
the primer pairs Halo-B4-FW/Halo-B7-RV and SZ002/
SZ003/SZ005 than using the primer pairs Trp-RW/
Trp-RV designed in this study. Screening of halogenase
genes only based on electrophoresis of PCR products is
not reliable. Further cloning and sequencing are required
to confirm the presence of halogenase genes.
The nine partially sequenced FDHs could be clustered
into two groups based on DNA sequences, Trp-
halogenases (I) and non-Trp-halogenases (II) (Fig. 2).
High homology was shared by halogenase genes from
strains with different phylogenetic affiliation. For ex-
ample, Streptomyces sp. 514 F shared almost identical
partial halogenase gene (phal514) with Nocardiopsis sp.
531 F (phal531). Streptomyces strains 551 F, 545 F and
543 F had nearly identical halogenase partial sequences
(phal551, phal545 and phal543). In addition, Streptomyces
strains 620 F and 604 F contained 99 % identical partial
halogenase sequences (phal620 and phal604). Therefore,
halogenases may have complex evolutionary history.
Representative halogenase partial genes were com-
pared against the NCBI GenBank database to search for
homologs. The partial halogenase of Streptomyces sp.
531 F (pHal531) shared 96 % nucleotide identity and
98 % amino acid identity with Trp-halogenase from
Sphingomonas melonis [GenBank: WP_017979780]. The
closest relative of the partial halogenase from Streptomy-
ces sp. 623 F (pHal623) was Trp-halogenases from Bre-
vundimonas sp. DS20 (98 % amino acid and nucleotide
identities) [GenBank: WP_054765358]. Interestingly, the
closest relatives of pHal531 and pHal623 are halogenases
from alphaproteobacteria rather than actinomycetes. In
addition, these alphaproteobacterial halogenases were ei-
ther partially cloned or predicted by genome sequencing.
Moreover, the alphaproteobacterial halogenases were not
located in any potential biosynthetic gene clusters. It
raises the question of roles played by halogenases in
non-actinomycetes, such as alphaproteobacteria that are
not perceived commonly as a natural product-producing
Fig. 1 Phylogenetic tree of 16S rRNA genes of halogenase-positive strains and their closest type strains
Table 1 Degenerative primers used for screening of halogenase genes
Primer Sequence (5´- 3´) Target regions Reference
Halo-B4-FW TTCCCSCGSTACCASATCGGSGAG FPRYHIGES [16]
Halo-B7-RV GSGGGATSWMCCAGWACCASCC GWYWVIPL
SZ002 TCGGYGTSGGCGARGCGACCRTCCC GVGEATIP [26]
SZ003 TSGGCGGCGGCACYGCSGGMTGGATG GGGTAGWM
SZ005 GCCGGAGCAGTCGAYGAASAGGTC DLFIDCSGFR
Trp-FW TCGGSGTSGGCGARGCSACCKT GVGEATF This study
Trp-RV CGGTRSWCTCCAGCGGCTCGACGAA FVEPLESSG
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group. Whether halogenases in alphaproteobacteria are
involved in halometabolite production is still unknown.
The closest biochemically characterized halogenases of
pHal531 and pHal623 were halogenase RebH from
Lechevalieria aerocolonigenes ATCC 39243 [GenBank:
CAC93722] [30] and halogenase Thal from Streptomyces
albogriseolus [GenBank: ABK79936] [28], sharing less
than 40 % nucleotide and amino acid identities. Hence,
pHal531 and pHal623 showed some novelty in sequence
and probably in physiological roles as well.
pHal551, representative of pHal545 and pHal543, had
highest homology (99 % nucleotide and amino acid iden-
tities) with three tryptophan 6-halogenases of Streptomyces
from mangrove soil. These closest strains are Streptomyces
fungicidicus strains MGR162 [GenBank: KF425752] and
MGR136 [GenBank: KF425746], and Streptomyces griseus
subsp. griseus strain MGR054 [GenBank: KF425729]. How-
ever, neither genomes of these mangrove strains were se-
quenced, nor further studies on their halogenases were
published. Therefore, no information of potential gene
clusters or products could be obtained from these highly
identical halogenases. Nevertheless, pHal551 showed sig-
nificant identities with halogenases known to be involved
in biosynthesis of identified halometabolites. For example,
pHal551 had 71 % nucleotide identity and 70 % amino acid
identity with Thal from Streptomyces albogriseolus
[GenBank: ABK79936]. It also showed 75 % nucleo-
tide identity and 70 % amino acid identity with RebH
from Lechevalieria aerocolonigenes ATCC 39243
[GenBank: CAC93722]. Therefore, pHal551 may re-
semble the characterized Trp-halogenases, indicating
that similar biosynthesis could occur in strain 551 F.
The three non-Trp-halogenases shared high identities
with putative halogenases from actinomycetes but low
identities with halogenases catalyzing recognized halome-
tabolites. The partial halogenase of Nocardiopsis sp. 597 F
(pHal597) shared 98 % nucleotide identity and 97 % amino
acid identity with putative halogenases from Streptomyces
sp. NRRL F-6628 [GenBank: WP_037845354] and Strepto-
myces griseus [GenBank: WP_030771994]. However,
pHal597 shared only 54 % nucleotide identity and 56 %
amino acid identity with the halogenase (Asm12) charac-
terized from Actinosynnema pretiosum [39]. pHal620 and
pHal604 shared 99 % nucleotide and amino acid identities
with halogenase of Streptomyces sp. L131(2011) [Gen-
Bank: JN035304], but were distinct from halogenases
involved in biosynthesis of known halometabolites.
Analysis and implication of the full-length halogenase
genes
Since the partial halogenases showed promising novelty
and diversity, representatives were chosen to clone full
coding sequences. Four full-length halogenase genes
were cloned based on genome walking of partial se-
quences from Streptomyces strains 604 F and 551 F, as
well as Nocardiopsis strains 597 F and 531 F. Both
Nocardiopsis strains and Streptomyces sp. 551 F were
isolated from deep-sea sediments from the high Arctic,
while Streptomyces sp. 604 F was obtained at a shallower
depth. Halogenases were reported to usually occur in
gene clusters for biosynthesis of related secondary me-
tabolites. Thus, a phylogenetic tree was built for the four
complete halogenases and the previously identified halo-
genases from known biosynthetic gene clusters (Fig. 3).
The complete halogenase gene (hal551) of Streptomy-
ces sp. 551 F was similar to Trp-halogenases involved in
biosynthesis of well-known halometabolites. The hal551
gene contained 1,605 bp encoding 534 amino acids. It
shared 85 % amino acid identity with multiple putative
Trp-halogenases from genome sequencing of Streptomy-
ces and 71 % amino acid identity with Thal from Strepto-
myces albogriseolus [GenBank: ABK79936] [28]. Thal
was a 6-Trp-halogenase that regioselectively catalyzed
chlorination or bromination at the 6-position of trypto-
phan to produce thienodolin, a growth-regulating factor
in plants [28]. The phylogenetic tree showed that
Hal551 was phylogenetically related to RebH (67 %
amino acid identity) from Lechevalieria aerocolonigenes
ATCC 39243 [GenBank: CAC93722] [30]. RebH was a
Trp-halogenase selectively catalyzing the halogenation of
7-position of tryptophan during the biosynthesis of
rebeccamycin. In addition, Hal551 clustered with other
Fig. 2 Phylogenetic tree of partial halogenase genes based on DNA sequences
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known Trp-halogenases, which regioselectively acted on
the 5, 6 or 7 position of tryptophan. Therefore, Hal551
is predicted to regioselectively catalyze tryptophan to
produce final halometabolites.
Hal531 was probably a new kind of Trp-halogenase. It
lay outside of the identified Trp-halogenases and Hal551
in the phylogenetic tree, but was not related to non-Trp-
halogenases. The complete gene still had highest identity
with halogenases from alphaproteobacteria, but remotely
related to actinobacterial halogenases as shown in the
tree (Fig. 3). It indicates that Hal531 likely represents an
ancestral form of Trp-halogenases that originated from
non-actinomycetes such as alphaproteobacteria. How-
ever, this hypothesis requires further investigation. Since
the function of these closely related halogenases in
alphaproteobacteria is unknown, it is of interest to
examine the roles of Hal531 in Nocardiopsis sp. 531 F.
Hal597 was a non-Trp-halogenase that implied the
potential of halometabolite biosynthesis of strain 597 F.
The complete gene consisted of 1,203 bp encoding 400
amino acids. Hal597 had highest amino acid identity
(98 %) with two putative halogenases in the draft
genomes of Streptomyces sp. NRRL F-6628 [GenBank:
WP_037845354] and Streptomyces griseus NRRL F-5618
Fig. 3 Phylogenetic tree of the full-length halogenases and previous halogenases identified in halometabolite biosynthesis. Phylogenetic tree was
built using amino acid sequences. Protein symbols/names, the producing strains, GenBank accession numbers in parentheses, and the corresponding
halometabolites underlined were given in order
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[GenBank: WP_030771994]. The two Streptomyces ge-
nomes were highly similar, especially the two contigs
(contig 32 of strain NRRL F-6628 and contig 44 of strain
NRRL F-5618) containing the halogenases. However, no
information on the two Streptomyces genomes as well as
the halogenases has been published in the literature. In
addition to the unidentified putative halogenases,
Hal597 shared 54 % amino acid identity with the halo-
genase (Asm12) from Actinosynnema pretiosum subsp.
auranticum ATCC 31565. Asm12 was identified in the
biosynthetic gene cluster of the maytansinoid antitumor
agent ansamitocin [39]. The phylogenetic tree also
showed that Hal597 clustered with Asm12 with 100 %
bootstrap support. Ansamitocin was 19-membered
macrocyclic lactams, with chlorine at position C-19 of
an aromatic ring. The biosynthetic gene cluster of ansa-
mitocin was split into two parts, which is uncommon.
Further investigation of hal597 in the context of genome
would provide more information on its possible gene
cluster and potential products.
Hal604 was predicted to be related to peptide-like
halometabolite biosynthesis. The complete gene was
1,443 bp in length encoding 480 amino acids, highly
similar with the halogenase gene previously cloned from
this strain in our lab [40]. Hal604 shared 99 % amino
acid identity with two putative halogenases in genomes
of Streptomyces sp. GBA 94–10 [GenBank: ESQ01308]
and Streptomyces sp. PVA 94–07 [GenBank: ESQ07118]
isolated from a sponge. The two draft genomes were
highly similar and contained almost identical halo-
genases as well as same flanking genes. The halogenases
were located in putative gene clusters which probably
produce glycopeptide-like secondary metabolites, as ana-
lyzed in antiSMASH [41]. In addition, Hal604 had 58 %
amino acid identity with two halogenases of Actino-
planes sp. ATCC 53533, which were identified in the
biosynthesis of the sulfated glycopeptide UK-68,597 [42].
Moreover, Hal604 clustered with halogenases involved in
biosynthesis of vancomycin [33], balhimycin [43], teico-
planin [44], A40926 [45] and complestatin [46], with
100 % bootstrap support in the tree. These products
were all built from peptides and modified by halogen-
ation and glycosylation, except complestatin that was a
heptapeptide without glycosylation. In addition, halogen-
ation occurred on the benzene rings derived from amino
acids of the above peptide-like macrocyclic compounds.
Taken together, Hal604 was expected to function in a
similar way in the biosynthesis of peptide-like macrocyc-
lic compounds. Since peptide-like macrocyclic natural
products are promising in antibacterial activity and other
bioactivities, Streptomyces sp. 604 F is worthy of further
investigation of natural products and the potential gene
clusters. However, no halometabolites were detected
under the regular conditions using HPLC-TOF MS
(High-Performance Liquid Chromatography Time-of-
flight Mass Spectrometry) analysis (Additional file 2). In
addition, qRT-PCR failed to detect the expression of
hal604 under the same conditions (Additional file 2).
Therefore, the HPLC-TOF MS and qRT-PCR data sug-
gested that hal604 was probably silent under the exam-
ined conditions.
Genome mining for target gene cluster
The failure in detection of predicted halometabolites
and expression of hal604 requires further genomic in-
vestigation to detect potential halogenase-containing
gene cluster in strain 604 F. Genome was sequenced
using Illumina platform. The gap closure and manual
correction of the draft genome are still in progress. As
expected, a potential gene cluster containing hal604 was
predicted by using the antiSMASH program. The gene
cluster was annotated as in Table 2, containing PKS,
modular NRPS genes and genes encoding modification
enzymes such as halogenase Hal604. The predicted
product of the hal604-containing gene cluster was a
peptide-derived molecule, corresponding to the predic-
tion based on Hal604 alone. Further investigations of the
hal604-containing gene cluster are planned to identify
the potential halometabolite and its biosynthesis. As an
example, it demonstrated that bioprospecting based on
halogenase and genomic data mining is promising to
discover strains with halometabolite biosynthesis poten-
tial. It is especially powerful to discover hidden products
usually missed in traditional chemical isolation, since
most encoding gene clusters are silent under normal
conditions. In addition, halogenases identified in this
study could be used in combinatorial biosynthesis to
produce new compounds with halogen modification.
This was demonstrated previously in PyrH and Thal that
halogenate at 5 and 6 positions of tryptophan respectively.
Co-expression of PyrH and Thal with rebeccamycin






4 condensation domain-containing protein
5 AMP-dependent synthetase and ligase
6 enoyl-CoA hydratase
7 chalcone and stilbene synthase domain protein (PKS)
8 cytochrome P450
9 phosphopantetheine-binding domain containing protein
10 condensation domain-containing protein (NRPS)
11 cytochrome P450
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biosynthetic genes produced new derivatives with novel
halogenation [47].
Conclusions
New halogenases with indications of potential halometa-
bolite production were discovered from Arctic marine
actinomycetes. It showed that halogenase gene-based
bioprospecting allowed rapid discovery of microbial
strains with potential in halometabolite production. In
addition, it could increase the robustness of halometabo-
lite discovery from cryptic or silent gene clusters. Further-
more, it suggested that Arctic marine actinomycetes were
promising targets for discovering new halogenases and
halometabolites. It encourages further investigation of
halometabolite biosynthetic gene clusters and their prod-
ucts from the almost untapped polar microorganisms.
Methods
Strains and 16S rRNA gene analysis
A total of 60 actinomycetes strains previously isolated
and kept in our lab from marine sediments at various
depths (173 m to 2531 m) of the Arctic, sampled during
the Third Chinese Arctic Scientific Expedition in 2008,
were used for halogenase gene screening (Additional file
1: Table S1). The strains were previously isolated using
serial dilution and plating on ISPII agar plates with nali-
dixic acid (15 μg ml−1). The plates were incubated at
15 °C for a few weeks. Colonies were streaked on new
agar plates for purification. Purified single colonies were
cultured in ISPII liquid medium at 15 °C. Genomic
DNA was extracted using the gDNA Bacteria Kit (Bio-
Dev-Tech Co., Beijing). Universal bacterial primers 27 F
(5´-AGAGTTTGATCCTGGCTCAG-3´) and 1492R (5´-
GGTTACCTTGTTACGACTT-3´) were used to amplify
16S rRNA genes. PCR products with the expected size
of approximately 1,500 bp were purified using the GEN-
Eray Agarose Gel DNA Purification Kit (GENEray
Biotechnology Co., Shanghai) and cloned into pMD18-T
vectors (TaKaRa). Positive clones of each PCR product
were sequenced using 27 F/1492R primers. The resulting
16S rRNA gene sequences were searched against the
EzTaxon-e database (http://eztaxon-e.ezbiocloud.net/).
Sequences were aligned using the ClustalW algorithm in
MEGA 6.0 [48], and phylogenetic trees were constructed
accordingly, using the neighbor-joining method with
1,000 bootstrap replicates. Bootstrap values less than 50
were not shown.
PCR-based screening for putative halogenase genes
Three primer pairs were used to amplify halogenases
(Table 1), including two previously designed primer
pairs, Halo-B4-FW/Halo-B7-RV [16] and SZ002/SZ003/
SZ005 [26], and a new primer pair specific for Trp-
halogenases (Trp-FW/Trp-RV) designed in this study.
Primers Halo-B4-FW/Halo-B7-RV and SZ002/SZ003/
SZ005 targeted FADH2-dependent halogenases at differ-
ent conserved regions (Table 1). Degenerate primers
Trp-FW/Trp-RV were designed based on the alignment
of known Trp-halogenases PrnA from Streptomyces viri-
dochromogenes [GenBank: WP_037891957] and Strepto-
myces rimosus subsp. rimosus ATCC 10970 [GenBank:
ELQ80637], PyrH from Streptomyces rugosporus [Gen-
Bank: AFV71318] and Streptomyces hygroscopicus subsp.
Jinggangensis TL101 [GenBank: YP_007697383], and
Thal from Streptomyces albogriseolus [GenBank:
AHD24351] and Streptomyces toxytricini [GenBank:
ADW94630]. Each 50 μL PCR mixture contained 1 ×
PCR buffer (without Mg2+), 1.5 mM MgCl2, 0.2 mM
dNTPs, 0.5 μM each primer, 0.2 μg genomic DNA, and
1 U Taq DNA polymerase in final concentration. The
touchdown PCR was programmed as follows: 3 min at
95 °C for 1 cycle; 30 s at 95 °C, 45 s at (Tm + 10) °C,
1 min at 72 °C for 10 – 15 cycles; 30 s at 95 °C, 45 s at
(Tm or Tm – 5) °C, 1 min at 72 °C for 25 cycles; and
Table 3 Primers designed for genome walking in this study
Gene Upstream primers (5´- 3´) Downstream primers (5´- 3´)
531 F 531USP1: GCTCCTTCAGCCAGAATTGATG 531DSP1: GATTACGCCTATCATTTCGATGCCTC
531USP2: ATCTTGCCGAAGCCGTGGATGT 531DSP2: CGCATCGTCGCCGCCAACCGCC
531USP3: ATCTTGCCGAAGCCGTGGATGT 531DSP3: ATGGCGACCTGTTCATCGACTGCTC
551 F 551USP1: GTGCTTGCGCTGGAACCAGTAGT 551DSP1: GGCTGGGCGTGGAAGATCCCGATGC
551USP2: CGAACGGGTGGTAGAAGTGGTCCGGC 551DSP2: GCGAGTTCTGCGAGATGTGGGGGCTGG
551USP3: CATCTTGAAGCTGGCGTTGCACTCCCGCA 551DSP3: GCCTGGGTGAAGAACGTGGTCAGCATCG
597 F 5GSP597-1: CCTTACGGGCGTGGTCCAGCA 3GSP597-1: GCCCACGTACTGACACAGGCCCAT
5GSP597-2: CCACCTGCGTCAGTGAACTCG 3GSP597-2: GCCGCCTACGTCGTCGACTCCAGC
5GSP597-3: CCATGTAGGGCAGCAGAGACTC 3GSP597-3: AGCGGAAAGATCGCCAAGGCATAC
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10 min at 72 °C for 1 cycle. PCR products with the ex-
pected size of 450 – 900 bp were cloned into pMD18-T
vectors (TaKaRa) and sequenced. The resulting se-
quences were searched against the GenBank database
using the BLASTx algorithm. Sequences that did not
match to halogenase genes in the database were defined
as false positives. DNA sequences of the partial halo-
genases were aligned with the ClustalW algorithm in
MEGA 6.0 to construct a neighbor-joining tree.
Cloning of full coding sequences of representative
halogenases
Two approaches of genome walking were used to amp-
lify the upstream and downstream of partial halogenase
genes, including modified thermal asymmetric interlaced
(TAIL)-PCR [49, 50], and SiteFinding-PCR [51]. Nested
specific primer sets designed for genome walking were
listed in Table 3. PCR products with expected size were
purified and cloned into pMD18-T vectors for sequen-
cing. The resulting sequences were assembled with the
partial halogenase gene sequences to obtain full coding
sequences identified by using the NCBI ORF Finder
(http://www.ncbi.nlm.nih.gov/gorf/gorf.html). The complete
halogenase genes were then analyzed by BLASTn and
BLASTp against the GenBank database. Neighbor-joining
tree was built for complete halogenases cloned in this study
with previous halogenases catalyzing the halogenation of
known secondary metabolites.
Genome sequencing and biosynthetic gene cluster
identification
The genome of strain 604 F was sequenced on the Illu-
mina HiSeq 2000 platform at the Beijing Genomics Insti-
tute (BGI). Sequences were assembled using SOAPdenovo
software [52]. Secondary metabolite biosynthetic gene
clusters were predicted by using the Antibiotics and Sec-
ondary Metabolites Analysis Shell (antiSMASH) [41].
Sequence accession numbers
Sequences produced in this study have been submitted
to GenBank under the accession numbers below: 16S
rRNA gene sequences (KJ017969, KP998446 – KP998453),
halogenase gene sequences (KF597545 – KF597550,
KP998454 – KP998458), and the biosynthetic gene cluster
containing the halogenase gene hal604 (KT439326).
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